SCHEMBL4201229

SCHEMBL4201229

CCOc1cc2c(cc1OCC)C(=O)C(=CC1CCN(Cc3ccccc3)CC1)C2

nearest known ligand 0.81

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ACHE P22303 14/20 0.81
BACE1 P56817 2/20 0.81
BCHE P06276 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4200691 0.99 ACHE (0.80) ACHEBACE1BCHE
SCHEMBL24401463 0.96 ACHE (0.89) ACHEBACE1BCHE
SCHEMBL8013133 0.90 ACHE (1.00) ACHEBACE1BCHE
SCHEMBL3086109 0.90 ACHE (1.00) ACHEBACE1BCHE
SCHEMBL29506653 0.90 ACHE (1.00) ACHEBACE1BCHE
SCHEMBL1877163 0.90 ACHE (1.00) ACHEBACE1BCHE
SCHEMBL29506655 0.90 ACHE (1.00) ACHEBACE1BCHE
Hydrochloric Acid SCHEMBL4205699 0.89 ACHE (0.98) ACHEBACE1BCHE
Hydrochloric Acid SCHEMBL29506654 0.89 ACHE (0.98) ACHEBACE1BCHE
SCHEMBL14601859 0.89 ACHE (0.89) ACHEBACE1BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050107432-A1 Sigma receptor binder containing indanone derivative EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-05-19 US claimed
EP-1468684-A1 SIGMA RECEPTOR BINDER CONTAINING INDANONE DERIVATIVE Eisai Co., Ltd. (JP) 2004-10-20 EP claimed
US-20090137629-A1 Sigma receptor binding agent containing indanone derivative IIMURA YOICHI 2009-05-28 US disclosed
US-20090137629-A1 Sigma receptor binding agent containing indanone derivative IIMURA YOICHI 2009-05-28 US disclosed
US-20090137629-A1 Sigma receptor binding agent containing indanone derivative IIMURA YOICHI 2009-05-28 US disclosed
US-20050107432-A1 Sigma receptor binder containing indanone derivative EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-05-19 US disclosed
EP-1468684-A1 SIGMA RECEPTOR BINDER CONTAINING INDANONE DERIVATIVE Eisai Co., Ltd. (JP) 2004-10-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137629-A1 Sigma receptor binding agent containing indanone derivative SIGMAR1, TMEM97, OPRK1 ACHE 608/4885BACE1 3238/4885BCHE 1667/4885
US-20050107432-A1 Sigma receptor binder containing indanone derivative SIGMAR1, OPRK1, TMEM97 ACHE 2667/4885BACE1 4457/4885BCHE 3026/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.